Controlled release of morphine from a poloxamer 407 gel

Int J Pharm. 2013 Aug 16;452(1-2):266-9. doi: 10.1016/j.ijpharm.2013.05.032. Epub 2013 May 21.

Abstract

Treatment of painful ulcers is discouraging. Topical morphine has been described as a useful therapeutic adjunct in some patients. In the development of a new analgesic product, we studied the in vitro release characteristics of a new topical formulation containing 0.5% (w/w) morphine-HCl in a poloxamer 407 (P407) based gel. A diffusion cell was used for measurement of in vitro release characteristics. The donor compartment (DC) and the receptor compartment (RC) were separated by a 5000 Da cellulose acetate membrane. The morphine-HCl release from this developed P407 based gel followed zero-order kinetics with a constant release of 150 μg cm(-2)h(-1). Our results support the use of this P407 gel as a sustained release topical formulation in the pharmacological treatment of painful ulcers. Future research welcomes a formulation with release characteristics leading to less frequent application.

MeSH terms

  • Analgesics, Opioid / chemistry*
  • Cellulose / analogs & derivatives
  • Cellulose / chemistry
  • Delayed-Action Preparations / chemistry
  • Drug Carriers / chemistry*
  • Gels
  • Membranes, Artificial
  • Morphine / chemistry*
  • Poloxamer / chemistry*

Substances

  • Analgesics, Opioid
  • Delayed-Action Preparations
  • Drug Carriers
  • Gels
  • Membranes, Artificial
  • Poloxamer
  • acetylcellulose
  • Morphine
  • Cellulose